예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>유럽 방사면역측정법 시장, 제품 유형(방사면역측정법 시약 및 키트, 방사면역측정법 분석기), 응용 분야(과학 연구 및 임상 진단), 최종 사용자(병원, 임상 진단 실험실, 학술 및 연구 기관, 제약 및 생물제약 산업, 계약 연구 기관 및 기타), 유통 채널(직접 입찰, 온라인 판매, 제3자 유통 및 기타)별 산업 동향 및 2030년까지의 예측.
유럽 방사면역측정법 시장 분석 및 통찰력
다양한 질병의 의료 보급률 증가, 치료 목적을 위한 의료 분야의 연구 증가, 검사에 사용되는 방사면역측정 키트를 사용한 내분비학 및 감염성 질환과 같은 다양한 검사, 그리고 의료비 지출 증가로 인해 사업 성장도 촉진될 것입니다. 다양한 질병을 사전 검사하기 위한 임상 연구 및 실험실은 시장이 확대될 수 있도록 합니다.
유럽 방사면역측정 시장은 2023년부터 2030년까지의 예측 기간 동안 성장할 것으로 예상됩니다. Data Bridge Market Research는 시장이 2023년부터 2030년까지의 예측 기간 동안 4.0%의 CAGR로 성장하고 있으며 2030년까지 1억 1,786만 달러에 도달할 것으로 예상한다고 분석합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2020-2016으로 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
제품 유형(방사면역측정 시약 및 키트, 방사면역측정 분석기), 응용 분야(과학 연구 및 임상 진단), 최종 사용자(병원, 임상 진단 실험실, 학술 및 연구 기관, 제약 및 생물제약 산업, 계약 연구 기관 및 기타), 유통 채널(직접 입찰, 온라인 판매, 제3자 유통 및 기타)별. |
|
적용 국가 |
독일, 프랑스, 영국, 이탈리아, 스페인, 러시아, 터키, 네덜란드, 벨기에, 스위스, 그리고 유럽의 다른 국가. |
|
시장 참여자 포함 |
시장에서 거래하는 주요 회사는 Institute of Isotopes, Beckman Coulter, Inc., EUROIMMUN Medizinische Labordiagnostika AG, PerkinElmer Inc., Merck KGaA, MyBioSource.com, Abcam plc., Tecan Trading AG, Immuno-Biological Laboratories Co,Ltd., MPBIOMEDICALS, DiaSource, Berthold Technologies GmbH & Co.KG, Hidex Oy 등입니다. |
시장 정의
방사면역측정법은 방사면역측정법의 기반이 되는 경쟁적 결합 측정법 이론인 방사표지 약물(일반적으로 125i)을 사용하는 이질적 측정법입니다. 이 방법에서는 항원과 항체가 서로 결합하고, 방사면역측정법은 항원이 얼마나 결합되어 있는지 확인하는 데 사용됩니다. 항체의 도움으로 이 방법의 과민성 덕분에 가장 작은 호르몬이나 약물 수치도 감지할 수 있습니다.
다양한 질병의 의료 보급률 증가, 치료 목적을 위한 의료 부문 연구 증가, 방사면역측정 키트를 사용한 내분비학 및 감염성 질환과 같은 다양한 검사, 의료비 지출 증가로 인해 사업 성장도 촉진될 것입니다. 다양한 질병을 사전 검사하기 위한 임상 연구 및 실험실은 시장이 확대될 수 있도록 합니다.
암과 감염과 같은 심각한 질병의 증가와 건강 관리에 대한 인식으로 실험실 검사의 성장은 다양한 검사 키트에 대한 수요 증가로 이어졌습니다. 이 측면은 또한 시약과 키트에 대한 수요 증가에 기여합니다.
유럽 방사면역측정 시장은 시장 참여자의 증가와 고급 키트 및 분석기의 가용성으로 인해 예측 연도에 성장하고 있습니다. 이와 함께 제조업체는 시장에 제품을 출시하기 위한 R&D 활동에 참여하고 있습니다. 증가하는 연구 개발 및 사전 테스트는 시장 성장을 더욱 촉진합니다. 그러나 또 다른 면역측정 테스트 기술이 방사면역측정을 지배하고 있어 예측 기간 동안 유럽 방사면역측정 시장의 성장을 방해할 수 있습니다.
유럽 방사면역측정법 시장 동향
이 섹션에서는 시장 동인, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
높은 처리량과 자동화된 절차에 대한 오류 없는 정확한 결과에 대한 수요 증가
방사면역측정법은 방사성 표지 약물(일반적으로 125i)을 사용하는 이질적 측정법으로, 방사면역측정법을 뒷받침하는 경쟁적 결합 측정법 이론입니다. 이 방법에서는 항원과 항체가 서로 결합하고, 방사면역측정법은 항원이 얼마나 결합되어 있는지 확인하는 데 사용됩니다.
따라서 이러한 심각한 질병과 바이러스의 증가로 인해 최근 몇 년 동안 생물학적 모델의 성장이 크게 나타났습니다. 이로 인해 생물학적 샘플에서 오류가 없고 정확한 결과에 대한 수요가 증가했습니다.
감염성 질병의 유병률 및 발생률 증가
감염성 질환은 유해한 물질(병원체)이 신체에 들어와 발생하는 질병입니다. 가장 흔한 원인은 바이러스, 박테리아, 진균, 기생충입니다. 감염성 질환은 일반적으로 오염된 음식이나 물, 벌레 물림을 통해 사람에서 사람으로 퍼집니다. 일부 감염성 질환은 사소하고 일부는 매우 심각합니다.
따라서 감염성 사례가 증가하고, 생물학적 모델의 성장은 최근 몇 년 동안 크게 나타났습니다. 이로 인해 이러한 측면을 감지하고 연구하기 위한 다양한 방사면역측정 기술에 대한 수요가 증가했으며, 이는 향후 몇 년 동안 시장 성장을 견인할 것으로 예상됩니다.
제약
높은 설치 비용 및 방사선면역측정 키트 유지 관리
방사면역측정 키트 가격은 시장에 큰 침체기를 가져올 것으로 예상되는데, 비용이 많이 들기 때문에 수요가 감소할 것으로 예상되기 때문이다.
따라서 생명 과학 분야에서 연구 개발을 늘리면 방사면역측정법 기술이 더욱 발전하게 됩니다. 이러한 발전은 방사면역측정법과 그 단위의 가격을 지속적으로 상승시키고 있으며, 이는 유럽 방사면역측정법 시장의 성장을 방해할 수 있습니다.
방사성 표지 화합물의 짧은 저장 수명
화학 화합물은 보관하는 동안 시간이 지남에 따라 분해됩니다. 분해 속도는 화합물에 따라 다릅니다. 그러나 방사성 동위 원소로 표지된 화합물은 일반적으로 방사성 분해로 인해 표지되지 않은 화합물보다 더 빨리 분해됩니다.
따라서 방사면역측정법에서 방사성 표지 동위 원소의 보관 및 사용에 대한 최대한의 주의가 필요하며, 분해 방지가 유럽 방사면역측정법 시장에 제약 요인으로 작용할 수 있습니다.
기회/도전
숙련된 전문가 부족
방사면역측정 기술은 매우 진보적이고 민감하여 혈액에서 작은 분자를 찾을 수 있습니다. 따라서 연구 목적과 암과 같은 질병 진단에 사용됩니다. 조직과 연구실도 동물이나 인간 혈청을 사용하는 특정 연구 목적으로 이 기술을 구현합니다. 그러나 이러한 기기를 사용할 수 없는 자격을 갖춘 인력이 부족하면 예측 기간 동안 방사면역측정 시장 성장이 억제될 수 있습니다.
게다가, 이 분야의 급속한 기술 발전은 숙련된 전문가의 부족으로 이어졌습니다. 숙련된 전문가의 부족은 전 세계적으로 장치를 다루는 데 큰 과제를 안겨줍니다.
최근 개발 사항
- 2022년 4월, 선도적인 과학 및 기술 기업인 머크는 생명 과학 사업 부문의 장기적 성장 전략을 지원하고 고객의 변화하는 요구에 더 잘 부응하기 위해 여러 조직 변화와 새로운 운영 모델을 발표했습니다. 이를 통해 회사는 생명 과학 사업 부문을 확장하는 데 도움이 되었습니다.
- 2022년 6월, PerkinElmer, Inc.의 계열사인 EUROIMMUN은 두 가지 CE 마크 검사법인 Anti-SARS-CoV-2 RBD ChLIA(IgG)와 Anti-SARS-CoV-2 Omicron ELISA(IgG)를 출시한다고 발표했습니다. 두 검사 시스템 모두 SARS-CoV-2에 대해 형성된 IgG 항체를 검출할 수 있으며 CE 마크를 허용하는 국가의 실험실에서 사용할 수 있습니다. 이를 통해 회사는 시장에서 사업을 확장할 수 있었습니다.
유럽 방사면역측정법 시장 범위
유럽 방사면역측정 시장은 제품 유형, 응용 분야, 최종 사용자 및 유통 채널로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 주요 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 분야를 식별하기 위한 전략적 결정을 내릴 수 있는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
제품 유형별
- 라디오면역측정 시약 및 키트
- 라디오면역측정기 분석기
제품 유형을 기준으로 유럽 방사면역측정 시장은 방사면역측정 시약 및 키트, 방사면역측정 분석기로 구분됩니다.
응용 프로그램으로
- 임상 진단
- 과학 연구
유럽 방사면역측정법 시장은 응용 분야를 기준으로 임상 진단용과 과학적 연구용으로 구분됩니다.
최종 사용자 에 의해
- 병원
- 임상진단연구소
- 학술 및 연구 기관
- 제약 및 생물제약 산업
- 계약 연구 기관
- 기타
유럽 방사면역측정법 시장은 최종 사용자를 기준으로 병원, 임상 진단 실험실, 학술 및 연구 기관, 제약 및 생물 제약 산업, 계약 연구 기관 등으로 구분됩니다.
유통 채널 별
- 직접 입찰
- 온라인 판매
- 제3자 배포
- 기타
유럽 방사면역측정법 시장은 유통 채널을 기준으로 직접 입찰, 온라인 판매, 제3자 유통 및 기타로 구분됩니다.
유럽 방사면역측정법 시장 지역 분석/통찰력
위에 언급된 대로 유럽 방사면역측정법 시장을 분석하고, 제품 유형, 응용 분야, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
독일은 시장 점유율과 수익 면에서 유럽 방사면역측정 시장을 지배하고 있으며 예측 기간 동안에도 지배력을 계속 유지할 것입니다. 이는 해당 지역에서 현미경 기술의 발전이 증가하고 R&D 투자가 증가하고 신제품이 출시되면서 시장이 활성화되고 있기 때문입니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 방사면역측정법 시장 점유율 분석
방사면역측정법 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 유럽의 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 포함됩니다. 위의 데이터 포인트는 방사면역측정법 시장에 초점을 맞춘 회사와만 관련이 있습니다.
유럽 방사면역측정법 시장의 주요 기업으로는 Isotopes, Beckman Coulter, Inc., EUROIMMUN Medizinische Labordiagnostika AG, PerkinElmer Inc., Merck KGaA, MyBioSource.com., Abcam plc., Tecan Trading AG, Immuno-Biological Laboratories Co,Ltd., MPBIOMEDICALS, DiaSource, Berthold Technologies GmbH & Co.KG, Hidex Oy 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE RADIOIMMUNOASSAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTYER’S FIVE FORCES
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5 INDUSTRY INSIGHTS:
6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY
6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES
7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES
7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS
7.2 RESTRAINTS
7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS
7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS
7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS
7.3 OPPORTUNITIES
7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE
7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS
7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES
8 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS
8.2.1 KITS
8.2.2 BUFFER
8.2.2.1 SOLUTION
8.2.2.2 POWDER
8.2.3 STANDARD CONCENTRATES
8.2.4 PRECIPITATING REAGENTS
8.2.5 RADIOISOTOPES
8.2.5.1 BETA EMITTERS
8.2.5.1.1 TRITIUM
8.2.5.1.2 CARBON-14
8.2.5.2 GAMMA EMITTERS
8.2.5.2.1 IODINE-125
8.2.5.2.2 CHROMIUM-51
8.2.5.2.3 COBALT-57
8.2.6 ANTIBODY/ANTISERUM
8.2.6.1 POLYCLONAL
8.2.6.2 MONOCLONAL
8.2.7 OTHERS
8.3 RADIOIMMUNOASSAY ANALYZER
9 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION
9.1 OVERVIEW
9.2 SCIENTIFIC RESEARCH
9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.2.2 RADIOIMMUNOASSAY ANALYZER
9.3 CLINICAL DIAGNOSIS
9.3.1 INFECTIOUS DISEASE TESTING
9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.1.2 RADIOIMMUNOASSAY ANALYZER
9.3.2 ALLERGY TESTING
9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.2.2 RADIOIMMUNOASSAY ANALYZER
9.3.3 ONCOLOGY TESTING
9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.3.2 RADIOIMMUNOASSAY ANALYZER
9.3.4 ENDOCRINE TESTING
9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.4.2 RADIOIMMUNOASSAY ANALYZER
9.3.5 TOXICOLOGY TESTING
9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.5.2 RADIOIMMUNOASSAY ANALYZER
9.3.6 AUTOIMMUNE DISEASE TESTING
9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.6.2 RADIOIMMUNOASSAY ANALYZER
9.3.7 OTHER DISEASE TESTING
10 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICAL DIAGNOSTIC LABORATORIES
10.4 ACADEMIC AND RESEARCH INSTITUTES
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY
10.6 CONTRACT RESEARCH ORGANISATIONS
10.7 OTHERS
11 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 ONLINE SALES
11.4 THIRD PARTY DISTRIBUTIONS
11.5 OTHERS
12 EUROPE RADIOIMMUNOASSAY MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 TURKEY
12.1.8 NETHERLANDS
12.1.9 BELGIUM
12.1.10 SWITZERLAND
12.1.11 REST OF EUROPE
13 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 PERKINELMER INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 MERCK KGAA
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BECKMAN COULTER, INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 ABCAM PLC
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 TECAN TRADING AG
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 DEMEDITEC DIAGNOSTICS GMBH
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 DIASOURCE
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 HIDEX OY
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 INSTITUTE OF ISOTOPES
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 KAMIYA BIOMEDICAL COMPANY
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 MP BIOMEDICALS
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 MYBIOSOURCE.COM.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE
TABLE 4 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 23 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 25 EUROPE HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 32 EUROPE DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 EUROPE THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 EUROPE RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 37 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 38 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 39 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 40 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 41 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 43 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 44 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 46 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 47 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 48 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 50 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 51 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 52 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 53 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 54 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 55 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 56 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 60 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 64 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 GERMANY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 69 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 70 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 71 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 72 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 73 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 74 GERMANY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 75 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 77 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 78 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 80 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 81 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 82 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 83 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 84 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 85 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 86 GERMANY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 GERMANY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 GERMANY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 89 GERMANY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 GERMANY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 91 GERMANY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 GERMANY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 GERMANY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 94 GERMANY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 GERMANY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 96 GERMANY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 97 FRANCE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 100 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 101 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 103 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 104 FRANCE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 106 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 107 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 108 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 110 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 111 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 112 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 113 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 114 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 115 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 116 FRANCE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 FRANCE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 FRANCE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 FRANCE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 FRANCE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 FRANCE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 FRANCE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 FRANCE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 124 FRANCE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 FRANCE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 126 FRANCE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 127 U.K. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 128 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 130 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 131 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 133 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 134 U.K. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 137 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 138 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 140 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 141 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 142 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 143 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 144 U.K. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 145 U.K. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 146 U.K. RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 147 U.K. SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 U.K. CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 149 U.K. INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 U.K. ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 U.K. ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 U.K. ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 U.K. TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 154 U.K. AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 U.K. RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 U.K. RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 157 ITALY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 160 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 161 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 163 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 164 ITALY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 167 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 168 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 170 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 171 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 172 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 173 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 174 ITALY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 175 ITALY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 176 ITALY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 ITALY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 ITALY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 ITALY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 ITALY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 ITALY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 ITALY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 ITALY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 184 ITALY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 ITALY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 ITALY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 187 SPAIN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 190 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 191 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 192 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 193 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 194 SPAIN RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 197 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 198 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 200 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 201 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 202 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 203 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 204 SPAIN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 205 SPAIN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 206 SPAIN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 207 SPAIN SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 SPAIN CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 SPAIN INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 210 SPAIN ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 SPAIN ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 SPAIN ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 SPAIN TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 214 SPAIN AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 SPAIN RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 SPAIN RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 217 RUSSIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 219 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 220 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 221 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 223 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 224 RUSSIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 225 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 226 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 227 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 228 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 230 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 231 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 232 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 233 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 234 RUSSIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 235 RUSSIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 236 RUSSIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 RUSSIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 RUSSIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 RUSSIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 RUSSIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 RUSSIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 RUSSIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 RUSSIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 244 RUSSIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 245 RUSSIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 246 RUSSIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 247 TURKEY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 248 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 250 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 251 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 253 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 254 TURKEY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 TURKEY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 TURKEY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 257 TURKEY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 258 TURKEY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 TURKEY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 260 TURKEY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 261 TURKEY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 262 TURKEY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 263 TURKEY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 264 TURKEY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 265 TURKEY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 266 TURKEY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 267 TURKEY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 TURKEY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 TURKEY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 TURKEY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 TURKEY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 272 TURKEY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 273 TURKEY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 274 TURKEY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 275 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 276 NETHERLANDS RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 NETHERLANDS RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 278 NETHERLANDS RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 279 NETHERLANDS BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 NETHERLANDS BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 281 NETHERLANDS BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 282 NETHERLANDS RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 283 NETHERLANDS BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 284 NETHERLANDS BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 285 NETHERLANDS BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 286 NETHERLANDS GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 287 NETHERLANDS GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 288 NETHERLANDS GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 289 NETHERLANDS ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 290 NETHERLANDS ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 291 NETHERLANDS ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 292 NETHERLANDS RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 293 NETHERLANDS RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 294 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 NETHERLANDS SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 NETHERLANDS CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 NETHERLANDS INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 298 NETHERLANDS ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 299 NETHERLANDS ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 300 NETHERLANDS ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 301 NETHERLANDS TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 302 NETHERLANDS AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 303 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 304 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 305 BELGIUM RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 306 BELGIUM RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 307 BELGIUM RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 308 BELGIUM RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 309 BELGIUM BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 310 BELGIUM BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 311 BELGIUM BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 312 BELGIUM RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 313 BELGIUM BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 314 BELGIUM BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 315 BELGIUM BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 316 BELGIUM GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 317 BELGIUM GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 318 BELGIUM GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 319 BELGIUM ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 320 BELGIUM ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 321 BELGIUM RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 322 BELGIUM RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 323 BELGIUM RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 324 BELGIUM SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 BELGIUM CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 326 BELGIUM INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 BELGIUM ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 BELGIUM ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 BELGIUM ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 BELGIUM TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 331 BELGIUM AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 332 BELGIUM RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 333 BELGIUM RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 334 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 335 SWITZERLAND RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 336 SWITZERLAND RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 337 SWITZERLAND RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 338 SWITZERLAND BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 339 SWITZERLAND BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 340 SWITZERLAND BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 341 SWITZERLAND RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 342 SWITZERLAND BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 343 SWITZERLAND BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 344 SWITZERLAND BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 345 SWITZERLAND GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 346 SWITZERLAND GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 347 SWITZERLAND GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 348 SWITZERLAND ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 349 SWITZERLAND ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 350 SWITZERLAND ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 351 SWITZERLAND RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 352 SWITZERLAND RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 353 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 SWITZERLAND SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 355 SWITZERLAND CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 SWITZERLAND INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 357 SWITZERLAND ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 358 SWITZERLAND ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 359 SWITZERLAND ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 360 SWITZERLAND TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 361 SWITZERLAND AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 362 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 363 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 364 REST OF EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 EUROPE RADIOIMMUNOASSAY MARKET: SEGMENTATION
FIGURE 2 EUROPE RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE RADIOIMMUNOASSAY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE RADIOIMMUNOASSAY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 EUROPE RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE RADIOIMMUNOASSAY MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE EUROPE RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOIMMUNOASSAY MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE RADIOIMMUNOASSAY MARKET
FIGURE 14 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022
FIGURE 19 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, 2022
FIGURE 23 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 EUROPE RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE
FIGURE 26 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 27 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 29 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 30 EUROPE RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022)
FIGURE 31 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022)
FIGURE 32 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 33 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 34 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030)
FIGURE 35 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
